Improving angiogenesis ameliorates the efficacy of ASO-based exon skipping for the treatment of Duchenne muscular dystrophy.

Mol Ther Nucleic Acids · 2026 · PMC12860987 · PMID 41630990

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although these changes did not reach statistical significance, the results suggest that LVRF has the capacity to enhance angiogenesis in TA muscles, thereby facilitating dystrophin restoration via exon skipping and contributing to amelioration of muscle fiber size in mdx mice.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.